All In Biotech

Drug Trial Radar · NCT06953934

A Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male Participants

Mass Balance Study of [14C] ABBV-932 Following Single Oral Dose Administration in Healthy Male Volunteers

Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

8

Actual

Start

May 4, 2026

Primary completion

Sep 14, 2026

Study completion Sep 14, 2026

Sponsor

Lead sponsor
AbbVieAbbVie (ABBV)
Sponsor type
Industry
First posted
May 1, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Basic science
FDA-regulated drug
No
Who can join
Male only, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The main objective of this study is to assess the safety and tolerability of ABBV-932 in healthy adult male participants.

Conditions

  • Healthy Volunteer

Interventions

  • ABBV-932Drug

    Oral Capsule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum Plasma Concentration (Cmax) of ABBV-932Time frame: Up to approximately 86 days
  2. Time to Cmax (Tmax) of ABBV-932Time frame: Up to approximately 86 days
  3. Terminal phase elimination rate constant (λz) of ABBV-932Time frame: Up to approximately 86 days
  4. Terminal Phase Elimination Half-Life (t1/2) of ABBV-932Time frame: Up to approximately 86 days
  5. Area Under the Concentration-Time Curve From Time 0 to Time t (AUCt) of ABBV-932Time frame: Up to approximately 86 days
  6. Area Under the Concentration-Time Curve From Time 0 to Infinity (AUCinf) of ABBV-932Time frame: Up to approximately 86 days
  7. Number of Participants Experiencing Adverse EventsTime frame: Up to approximately 103 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • ICON Clinical Research /ID# 270490

    Groningen, Netherlands

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.